Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells

Ji, LJ; Tang, YY; Pang, XM; Zhang, YC

Zhang, YC (reprint author), Sixth Peoples Hosp Qingdao, Dept Hepatol 7, Qingdao, Shandong, Peoples R China.

MEDICAL SCIENCE MONITOR, 2019; 25 (): 5823

Abstract

Background: Serine hydroxymethyltransferase 2 (SHMT2) is a key enzyme in one-carbon cell metabolism, including in liver cancer. However, the associati......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索